Biocryst Adds $350 Million In New Financing With Royalty Pharma And Omers Capital Markets
Amount Raised
$350 Million
Round Type
Funding Round
DurhamBiotechnologyHealth CareTherapeuticsDescription
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), Royalty Pharma plc (Nasdaq: RPRX) and OMERS Capital Markets (OMERS), today announced transactions totaling $350 million in new funding for BioCryst, with all funds immediately available at closing.
Quick answer
BioCryst Pharmaceuticals raised $350 Million in a Funding Round round, dated November 22, 2021. BioCryst Pharmaceuticals is based in Durham, North Carolina, United States.
- How much did BioCryst Pharmaceuticals raise?
- BioCryst Pharmaceuticals raised $350 Million in a Funding Round round on November 22, 2021.
- What does BioCryst Pharmaceuticals do?
- BioCryst is focused on developing novel therapies for diseases with significant unmet needs.
- Where is BioCryst Pharmaceuticals based and how big is it?
- BioCryst Pharmaceuticals is based in Durham, North Carolina, United States. Fundz records about 440 employees.
- Who are the decision-makers at BioCryst Pharmaceuticals?
- Fundz holds 5 contacts at BioCryst Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as BioCryst Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Eikon Therapeutics raised $518M (Series B) on January 6, 2022.
- Eikon Therapeutics raised $518M on January 6, 2022.
- Innate Pharma raised $31M (Grant) on January 5, 2022.
- Tessera Defense & Homeland Security Inc. raised $3M (Seed) on January 4, 2022.
- Arbutus raised $15M on December 30, 2021.
- Arcutis raised $225M (Debt Financing) on December 23, 2021.
Who to call at BioCryst Pharmaceuticals, and when
A new round usually means BioCryst Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioCryst Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioCryst Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioCryst Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioCryst Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioCryst Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.